After the registration of the vaccine against coronavirus infection, developed by the Gamaleya National Research Center for Epidemiology and Microbiology, a post-registration study will be carried out in Moscow. This was reported on Friday, August 7, in the capital’s health department.
“The Moscow Department of Health, together with the Russian Ministry of Health, after official registration, will conduct a post-registration study of a vaccine against coronavirus,” the Moscow city news agency quoted a representative of the department.
Volunteers from among doctors and teachers will be invited to participate in the study.
Earlier on the same day, Deputy Minister of Health of the Russian Federation Oleg Gridnev said that Russia would become the first country in the world to register a vaccine against coronavirus. The drug developed by the center. N. Gamalei, will be registered on August 12, according to the website kp.ru.
Health care workers and the elderly will be the first to receive this vaccine.
The spread of the SARS-CoV-2 coronavirus, which causes the COVID-19 disease, began at the end of December last year. The Chinese city of Wuhan became the hotbed of infection. For several months, the disease has spread to more than 210 countries of the world. On March 11, WHO announced a coronavirus pandemic.